Climbers using xenon gas to climb Everest
Mount Everest guiding companies are marketing xenon gas inhalation—banned in sports for stimulating red blood cell production—as a way to compress the traditional 6–8 week acclimatization schedule into a one‑week, high‑priced summit attempt. Commenters question both the medical safety and ethics of this shortcut, citing elevated risks of altitude illness, blood clots, and overreliance on Sherpa labor in an already dangerous environment. The trend is framed as part of Everest’s long‑running commercialization and “pay‑to‑win” dynamic, where money and technology increasingly substitute for skill, preparation, and respect for the mountain.
Medical and Physiological Concerns
- Traditional 6–8 week acclimatization is framed as essential for red blood cell adaptation, vascular changes, and respiratory conditioning that cannot be safely rushed.
- Critics argue xenon-induced EPO boosts create “thicker blood” atop already increased altitude viscosity, raising risks of clots, stroke, and heart attack.
- Rapid ascent without acclimatization is linked to higher risk of AMS, HAPE, and HACE, especially above 8,000m.
- Individual responses to xenon/EPO are said to be unpredictable, making safe dosing at extreme altitude unclear.
- Some ask whether there is actual evidence of increased mortality from xenon use versus speculation; the thread does not provide hard data.
Performance Enhancement, Legality, and Alternatives
- Xenon is noted as banned by WADA; using it for running a marathon, for instance, would be considered doping.
- Compared with altitude tents and hypoxic training masks, xenon is seen as a more convenient but potentially riskier shortcut.
- Hypoxic tents are described as noisy, hot, uncomfortable, requiring 12+ hours/day; their benefits for non-elite athletes are questioned.
- Hypoxic masks for casual or detrained athletes are warned against as counterproductive.
Cost, Commercialization, and “Pay-to-Win”
- Xenon sessions are reported at ~$5,000 for 30 minutes, with full xenon-assisted Everest packages in the six-figure range.
- Several comments highlight xenon, high-end guiding, and fixed-rope “expedition style” as symbols of Everest becoming a rich-person, pay-to-win objective.
- Others reply that even guided, oxygen-assisted Everest remains extremely demanding and beyond what most people can do.
Ethics, Meaning, and Sherpa Risk
- Strong criticism of clients who use xenon, heavy Sherpa support, and minimal skills while claiming “I climbed Everest”; likened to being pulled through a marathon in a rickshaw.
- Concern that xenon-shortened climbs increase danger for both clients and Sherpas, with limited ability to retreat during acclimatization.
- Counterpoint: people knowingly accept risk; Sherpas and local economies depend on high-paying expeditions.
Skepticism About the “Trend”
- Some suspect the xenon-Everest idea is mostly marketing: a Financial Times feature and PDFs are hosted by the very company selling $5k xenon sessions.
- Unclear whether this is a real, growing practice or a publicity-driven one-off.
Xenon’s Other Effects
- Xenon is noted as a potent but expensive anesthetic and psychoactive gas, potentially acting via lipid solubility and possibly microtubule-related mechanisms, though details remain scientifically unsettled.